PortfoliosLab logoPortfoliosLab logo
RCKT vs. XLK
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

RCKT vs. XLK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Rocket Pharmaceuticals, Inc. (RCKT) and State Street Technology Select Sector SPDR ETF (XLK). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RCKT achieves a -1.14% return, which is significantly lower than XLK's 28.25% return. Over the past 10 years, RCKT has underperformed XLK with an annualized return of -19.13%, while XLK has yielded a comparatively higher 25.48% annualized return.


RCKT

1D
0.29%
1M
17.23%
YTD
-1.14%
6M
0.58%
1Y
31.94%
3Y*
-44.85%
5Y*
-39.69%
10Y*
-19.13%

XLK

1D
-4.14%
1M
2.23%
YTD
28.25%
6M
26.51%
1Y
52.47%
3Y*
30.61%
5Y*
21.34%
10Y*
25.48%
*Multi-year figures are annualized to reflect compound growth (CAGR)

RCKT vs. XLK - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
RCKT
Rocket Pharmaceuticals, Inc.
-1.14%-72.08%-58.06%53.14%-10.35%-60.19%140.95%53.58%41.95%-57.21%
XLK
State Street Technology Select Sector SPDR ETF
28.25%24.61%21.63%56.02%-27.73%34.74%43.62%49.86%-1.68%34.26%

Correlation

The correlation between RCKT and XLK is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.29

Correlation (3Y)
Calculated over the trailing 3-year period

0.31

Correlation (5Y)
Calculated over the trailing 5-year period

0.38

Correlation (10Y)
Calculated over the trailing 10-year period

0.35

Correlation (All Time)
Calculated using the full available price history since Feb 18, 2015

0.34

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RCKT vs. XLK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RCKT
RCKT Risk / Return Rank: 5858
Overall Rank
RCKT Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
RCKT Sortino Ratio Rank: 6161
Sortino Ratio Rank
RCKT Omega Ratio Rank: 5858
Omega Ratio Rank
RCKT Calmar Ratio Rank: 5757
Calmar Ratio Rank
RCKT Martin Ratio Rank: 5858
Martin Ratio Rank

XLK
XLK Risk / Return Rank: 6666
Overall Rank
XLK Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
XLK Sortino Ratio Rank: 6161
Sortino Ratio Rank
XLK Omega Ratio Rank: 6464
Omega Ratio Rank
XLK Calmar Ratio Rank: 6868
Calmar Ratio Rank
XLK Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RCKT vs. XLK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Rocket Pharmaceuticals, Inc. (RCKT) and State Street Technology Select Sector SPDR ETF (XLK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


RCKTXLKDifference
Sharpe ratioReturn per unit of total volatility

-1.84

Sortino ratioReturn per unit of downside risk

-1.52

Omega ratioGain probability vs. loss probability

1.14

1.38

-0.23

Calmar ratioReturn relative to maximum drawdown

0.63

3.31

-2.68

Martin ratioReturn relative to average drawdown

1.40

10.56

-9.16

RCKT vs. XLK - Sharpe Ratio Comparison

The current RCKT Sharpe Ratio is 0.40, which is lower than the XLK Sharpe Ratio of 2.25. The chart below compares the historical Sharpe Ratios of RCKT and XLK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

RCKT vs. XLK - Drawdown Comparison

The maximum RCKT drawdown since its inception was -96.70%, which is greater than XLK's maximum drawdown of -82.05%. Use the drawdown chart below to compare losses from any high point for RCKT and XLK.


Loading charts...

Drawdown Indicators


RCKTXLKDifference

Max Drawdown

Largest peak-to-trough decline

-96.70%

-82.05%

-14.65%

Max Drawdown (1Y)

Largest decline over 1 year

-50.94%

-15.92%

-35.02%

Max Drawdown (3Y)

Largest decline over 3 years

-92.71%

-25.66%

-67.05%

Max Drawdown (5Y)

Largest decline over 5 years

-95.24%

-33.56%

-61.68%

Max Drawdown (10Y)

Largest decline over 10 years

-96.46%

-33.56%

-62.90%

Current Drawdown

Current decline from peak

-95.08%

-6.96%

-88.12%

Average Drawdown

Average peak-to-trough decline

-68.61%

-34.90%

-33.71%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.87%

4.98%

+17.89%

Volatility

RCKT vs. XLK - Volatility Comparison

Rocket Pharmaceuticals, Inc. (RCKT) has a higher volatility of 18.36% compared to State Street Technology Select Sector SPDR ETF (XLK) at 12.51%. This indicates that RCKT's price experiences larger fluctuations and is considered to be riskier than XLK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RCKTXLKDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.36%

12.51%

+5.85%

Volatility (6M)

Calculated over the trailing 6-month period

51.53%

19.70%

+31.83%

Volatility (1Y)

Calculated over the trailing 1-year period

79.34%

23.48%

+55.86%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

78.59%

25.37%

+53.22%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

84.10%

24.71%

+59.39%

Dividends

RCKT vs. XLK - Dividend Comparison

RCKT has not paid dividends to shareholders, while XLK's dividend yield for the trailing twelve months is around 0.43%.


PositionTTM20252024202320222021202020192018201720162015
RCKT
Rocket Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XLK
State Street Technology Select Sector SPDR ETF
0.43%0.54%0.66%0.76%1.04%0.65%0.92%1.16%1.60%1.37%1.74%1.79%

Frequently Asked Questions


RCKT and XLK have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RCKT has higher volatility (18.36%) compared to XLK (12.51%). In terms of maximum drawdown, RCKT dropped -96.70% vs XLK's -82.05%.

XLK currently has the higher Sharpe Ratio (2.25 vs 0.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RCKT and XLK

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer